ARCHIVES

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

CyberKnife Delivers 100 Percent PFS at 18.3 Month Followup

January 27, 2012

In Brief: Paul Rambaut Leaving NCI For NATO Position; Niederhuber New Cancer Commission Chairman

December 9, 1988

Pressure Builds On President To Sign Authorization Bill; No Movement Yet On Appropriations Measure

November 8, 1985

NCI Forms Task Force To Examine Marin County Breast Cancer Incidence

November 15, 2002

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982

President, First Lady Visit Clinical Center, Hail ‘Compassion’

January 5, 1990